News from the FDA/CDC
October 28, 2024
Duloxetine Bottles Recalled by FDA Because of Potential Carcinogen
October 28, 2024
MDedge Psychiatry
October 23, 2024
Gotistobart Trial for NSCLC on Partial Clinical Hold
October 23, 2024
MDedge Hematology and Oncology
October 7, 2024
Tirzepatide Shortage Resolved? FDA Says Yes, Compounders No
October 7, 2024
MDedge Family Medicine